Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohnʼs disease†

2009; Oxford University Press; Volume: 16; Issue: 7 Linguagem: Inglês

10.1002/ibd.21164

ISSN

1536-4844

Autores

Dan J. Stein, Ashwin N. Ananthakrishnan, Mazen Issa, John B. Williams, Dawn B. Beaulieu, Yelena Zadvornova, Anita Ward, Kathryn Johnson, Josh F. Knox, Sue Skaros, David G. Binion,

Tópico(s)

Chronic Lymphocytic Leukemia Research

Resumo

BackgroundInfliximab is efficacious in the management of moderate to severe Crohn's disease (CD). There are limited data regarding performance of infliximab in patients who require reinitiation of maintenance dosing following previous irregular exposure.

Referência(s)